COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 1 for:    LIMT HDV
Previous Study | Return to List | Next Study

A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection (LIMT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02765802
Recruitment Status : Completed
First Posted : May 9, 2016
Last Update Posted : July 25, 2019
Information provided by (Responsible Party):
Eiger BioPharmaceuticals